Nasdaq Stockholm Welcomes XVIVO Perfusion to the Main

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nasdaq Stockholm Welcomes XVIVO Perfusion to the Main Market

Stockholm, November 28, 2016 — Nasdaq (Nasdaq: NDAQ) announced that XVIVO Perfusion AB (short name: XVIVO), a Mid Cap company within the Healthcare sector, has started trading of its shares on the main market of Nasdaq Stockholm. XVIVO Perfusion is the 75 th company to list at Nasdaq’s Nordic markets* in 2016.

XVIVO Perfusion is a medical technology company headquartered in Gothenburg, Sweden, with presence Lund, Sweden and in Denver, USA. The company is rooted in medical science and its core business is in organ preservation before transplantation. XVIVO Perfusion focuses on developing optimized solutions for organ and tissue preservation and perfusion in connection with transplantation. They have more than 15 years of transplant industry experience and are marketing their products worldwide. XVIVO Perfusion is dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation. For more information, please visit www.xvivoperfusion.com

“Our vision is that ‘no patient should have to die waiting for an organ’. The entrance to the main market of Nasdaq Stockholm is a step to further strengthen our shareholder base. This will secure that we can follow through in taking our promising product development projects through regulatory approval and to the market to the benefit of patients waiting for an organ.” says Magnus Nilsson, CEO of XVIVO Perfusion AB.

 “We welcome XVIVO Perfusion to our main market, where they will make a compelling addition to our healthcare sector” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “XVIVO is an innovative company doing important work, and we look forward to continue supporting them as a publicly traded company.”

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.

About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of over $10.0 trillion and nearly approximately 18,000 corporate clients. To learn more, visit nasdaq.com/ambition or business.nasdaq.com .

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius .

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

Media Relations Contact: +       David Augustsson +       +46 73 449 61 35 +       david.augustsson@nasdaq.com  
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 3

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Brady Corporation to Host Earnings Conference Call

Updated Category News Views 55

Brady Corporation to Host Earnings Conference Call Brady Corporation (NYSE: BRC) is preparing to release its financial results for the fourth quarter of fiscal 2024 on an upcoming Friday. This important announcement will give stakeholders a clear view of the company's performance during this period. Details of the Earnings Conference Call The earnings conference call is...

Continue Reading
Johnson Fistel Probes Baldwin Insurance Group Over Financial Concerns

Updated Category News Views 97

Investigation Launched into Baldwin Insurance Group Leading law firm Johnson Fistel, LLP has embarked on an important investigation focusing on Baldwin Insurance Group, Inc. (NASDAQ: BWIN) concerning potential breaches in securities laws. This inquiry is prompted by serious allegations raised by a financial analysis firm regarding Baldwin’s financial practices. Concerns...

Continue Reading
InspireMD's Milestone $58 Million Financing Fuels Growth

Updated Category News Views 167

InspireMD Raises $58 Million Through Financing In a significant move to bolster its expansion into the United States market, InspireMD, Inc. (NASDAQ: NSPR), a pioneering developer of innovative carotid stenting technology, has successfully secured approximately $58 million in combined gross proceeds. This funding comes through an equity private placement and the exercise...

Continue Reading
Orion180 Partners with Vexcel for Enhanced Insurance Operations

Updated Category News Views 71

Enhancing Insurance Solutions with Vexcel Orion180 is making significant strides in the insurance industry by enhancing its underwriting and claims operations through a strategic partnership with Vexcel Data Program. This collaboration enables Orion180 to access high-resolution aerial imagery and sophisticated property analytics that are essential for effective real-time...

Continue Reading
AS Tallink Grupp’s Q3 2024 Report: Insights and Financials

Updated Category News Views 179

Overview of AS Tallink Grupp’s Q3 2024 Financial Performance The latest financial results for AS Tallink Grupp reveal a challenging yet insightful third quarter, reflecting the impact of global economic conditions and consumer behaviors. The Q3 2024 results were presented during an investor webinar where participants had the opportunity to engage and ask pertinent...

Continue Reading